Tender Details
Tender Title / Description
| Tender Title | ECHS CFA RE-01/2025-26 |
|---|---|
| Tender Description | formoterol 6 mcg + glycopyrronium 25 mcg (dry powder inhaler) bott 30 capsulesspray diclofenac (diclofenac diethylamine , methyl salicylate & menthol topical spray) pack of 35 gmdisposable insulin pen needles 32 g 4mm box of 100glimepiride 2mg + metformin 500mg tabatorvastatin 10 mg tab pantoprazole 40mg tab diclofenac gel 1% tube of 30 gm cilnidipine 10 mg tabamoxycillin 500 mg +clavulanic acid 125 mg tabinj human insulin analogue mix 25/75 cartridge(25 % insulin lispro and 75 % insulin lispro protamine suspension) 100 u/ml (3 ml cart)omeprazole 20 mg cap sofosbuvir 400mg + velpatasvir 100mg cap bott of 28 tabmetformin 0.5g tab atorvastatin 20 mg tab clopidogrel 75 mg + aspirin 75 mg tabthyroxin sodium 125 mcg (bott of 120 tablet) tab seroflo 250 syncyobreathe mdi salmeterol 25 mcg (as salmeterol xinafoate ip) fluticasone propionate ip 250 mcg suspended in propllent hfa 134a q.s. contains absolute alcohol ip 3.07% v/v (120 mdi - with dose counter)glimepride 1 mg + metformin 500 mg |
| Comments | formoterol 6 mcg + glycopyrronium 25 mcg (dry powder inhaler) bott 30 capsulesspray diclofenac (diclofenac diethylamine , methyl salicylate & menthol topical spray) pack of 35 gmdisposable insulin pen needles 32 g 4mm box of 100glimepiride 2mg + metformin 500mg tabatorvastatin 10 mg tab pantoprazole 40mg tab diclofenac gel 1% tube of 30 gm cilnidipine 10 mg tabamoxycillin 500 mg +clavulanic acid 125 mg tabinj human insulin analogue mix 25/75 cartridge(25 % insulin lispro and 75 % insulin lispro protamine suspension) 100 u/ml (3 ml cart)omeprazole 20 mg cap sofosbuvir 400mg + velpatasvir 100mg cap bott of 28 tabmetformin 0.5g tab atorvastatin 20 mg tab clopidogrel 75 mg + aspirin 75 mg tabthyroxin sodium 125 mcg (bott of 120 tablet) tab seroflo 250 syncyobreathe mdi salmeterol 25 mcg (as salmeterol xinafoate ip) fluticasone propionate ip 250 mcg suspended in propllent hfa 134a q.s. contains absolute alcohol ip 3.07% v/v (120 mdi - with dose counter)glimepride 1 mg + metformin 500 mg |
Important Dates
| Published Date | |
|---|---|
| Due Date | 05 Jun 2025 00:00:00 |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |